Pulmonary Arterial Hypertension: Diagnosis and Treatment

被引:20
|
作者
Barnett, Christopher F. [1 ,2 ]
Alvarez, Paulino [3 ]
Park, Myung H. [4 ]
机构
[1] Medstar Heart & Vasc Inst, 110 Irving St Northwest, Washington, DC 20010 USA
[2] NIH, Dept Crit Care Med, 10 Ctr Dr,Room 2C145, Bethesda, MD 20892 USA
[3] Houston Methodist Hosp, Dept Cardiol, Methodist DeBakey Heart & Vasc Ctr, 6550 Fannin St,Smith Tower,Suite 1901, Houston, TX 77030 USA
[4] Houston Methodist Hosp, Div Heart Failure & Transplant, Dept Cardiol, Methodist DeBakey Heart & Vasc Ctr, 6550 Fannin St,Smith Tower,Suite 1901, Houston, TX 77030 USA
关键词
Pulmonary arterial hypertension; Echocardiography; Right heart catheterization; Prostacyclin; Phosphodiesterase inhibitor; Endothelin antagonist; ENDOTHELIN RECEPTOR ANTAGONIST; RANDOMIZED CONTROLLED-TRIAL; 5 INHIBITOR THERAPY; ORAL TREPROSTINIL; HEART-FAILURE; DOUBLE-BLIND; ECHOCARDIOGRAPHY; PROSTACYCLIN; MULTICENTER; MANAGEMENT;
D O I
10.1016/j.ccl.2016.04.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary arterial hypertension (PAH) is a specific, rare disease characterized by a well-described pattern of pulmonary vascular remodeling. The elevated pulmonary artery pressure in PAH results in increased right ventricular afterload, which, if untreated, leads rapidly to right ventricular failure and death. Recent marked expansion in knowledge about PAH has resulted in the development of effective therapies that improve quality of life and survival. However, delays in diagnosis and suboptimal treatment remain significant barriers to achieving optimal patient outcomes. Continued success in raising PAH awareness, earlier diagnosis, and the availability of new therapies mean a promising future for PAH patients.
引用
收藏
页码:375 / +
页数:16
相关论文
共 50 条
  • [1] Pulmonary arterial hypertension: diagnosis and treatment
    Sadowski, Marcin
    Janion-Sadowska, Agnieszka
    Letek, Agnieszka
    Raczynski, Grzegorz
    Zandecki, Lukasz
    [J]. MEDICAL STUDIES-STUDIA MEDYCZNE, 2013, 29 (03) : 273 - 279
  • [2] Diagnosis and treatment of pulmonary arterial hypertension
    Channick, R
    Williamson, TL
    [J]. CARDIOLOGY CLINICS, 2004, 22 (03) : 441 - +
  • [3] Guidelines on diagnosis and treatment of pulmonary arterial hypertension
    Galiè, N
    Torbicki, A
    Barst, R
    Dartevelle, P
    Haworth, S
    Higenbottam, T
    Olschewski, H
    Peacock, A
    Pietra, G
    Rubin, LJ
    Simonneau, G
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2005, 58 (05): : 523 - 566
  • [4] Diagnosis and treatment of pulmonary arterial hypertension: a review
    Ruopp, N. F.
    Cockrill, B. A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (09): : 892 - 892
  • [5] Pulmonary Arterial Hypertension: An Update on Diagnosis and Treatment
    Stringham, Richard
    Shah, Nipa R.
    [J]. AMERICAN FAMILY PHYSICIAN, 2010, 82 (04) : 370 - 377
  • [6] Challenges in the diagnosis and treatment of pulmonary arterial hypertension
    Vachiery, Jean-Luc
    Gaine, Sean
    [J]. EUROPEAN RESPIRATORY REVIEW, 2012, 21 (126): : 313 - 320
  • [7] Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension
    Ghofrani, Hossein A.
    Wilkins, Martin W.
    Rich, Stuart
    [J]. CIRCULATION, 2008, 118 (11) : 1195 - 1201
  • [8] Diagnosis and treatment of pediatric pulmonary arterial hypertension
    Farhat, Nesrine
    Lador, Frederic
    Beghetti, Maurice
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2019, 17 (03) : 161 - 175
  • [9] Pulmonary arterial hypertension - the challenge in diagnosis and treatment
    Jansa, Pavel
    Aschermann, Michael
    Ambroz, David
    Linhart, Ales
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S3 - S9
  • [10] Diagnosis and Treatment of Pulmonary Arterial Hypertension A Review
    Ruopp, Nicole F.
    Cockrill, Barbara A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (14): : 1379 - 1391